about
Assuring Consistent Performance of an Insulin-Like Growth Factor 1 MALDImmunoassay by Monitoring Measurement Quality IndicatorsSingle-nucleotide polymorphism in the 5-α-reductase gene (SRD5A2) is associated with increased prevalence of metabolic syndrome in chemotherapy-treated testicular cancer survivors.A fully validated liquid chromatography-mass spectrometry method for the quantification of the soluble receptor of advanced glycation end-products (sRAGE) in serum using immunopurification in a 96-well plate format.Assessment of Sample Preparation Bias in Mass Spectrometry-Based Proteomics.Affimers as an Alternative to Antibodies in an Affinity LC-MS Assay for Quantification of the Soluble Receptor of Advanced Glycation End-Products (sRAGE) in Human SerumQuantification of the soluble Receptor of Advanced Glycation End-Products (sRAGE) by LC-MS after enrichment by strong cation exchange (SCX) solid-phase extraction (SPE) at the protein levelA quantitative LC-MS/MS method for insulin-like growth factor 1 in human plasmaCigarette Smoking Acutely Decreases Serum Levels of the COPD Biomarker sRAGEReply to Biswas: Acute and Chronic Effects of Cigarette Smoking on sRAGECigarette smoking prior to blood sampling acutely affects serum levels of the chronic obstructive pulmonary disease biomarker surfactant protein DPre- and Post-analytical Factors in Biomarker DiscoveryConfounding Factors Affecting sRAGE as a Biomarker for Chronic Obstructive Pulmonary DiseaseQuantification of surfactant protein D (SPD) in human serum by liquid chromatography-mass spectrometry (LC-MS)
P50
Q36361741-3A0C1AEE-CB9C-446B-AE3D-ECEA9C054A8EQ40987520-475E3C92-1DA2-4652-8E64-451F3728D3DBQ52368657-460838DF-66B1-4349-AD5A-AF9809CB1E0DQ53278019-DA0EC91C-FBF2-40B2-A958-DE31B7AE4213Q56888831-A28CA23E-8FA7-48F5-8678-3EE77BF297F1Q57712718-DCAA43A3-AF8B-4784-9196-206B47E0C527Q57712737-76BE418F-A437-48D9-A59D-D143DBC33456Q57712742-4A254EAD-9E6B-4CBD-829F-B9DC8E83776AQ64085137-52F790AE-5C5D-4233-9CBF-5FED775A3CEDQ90126145-200CE020-4AAF-41EC-8498-0B8A205BAF5DQ92249100-BD004AC7-7D82-4590-8AE7-55B040172122Q92477145-7B6AC9C1-B42F-49D4-852F-53AE63F4E57BQ92568978-258D5865-172B-4F2E-901A-16A612365D2A
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0003-3503-1694
@en
name
Frank Klont
@ast
Frank Klont
@en
Frank Klont
@es
Frank Klont
@nl
type
label
Frank Klont
@ast
Frank Klont
@en
Frank Klont
@es
Frank Klont
@nl
altLabel
F. Klont
@nl
prefLabel
Frank Klont
@ast
Frank Klont
@en
Frank Klont
@es
Frank Klont
@nl
P106
P21
P31
P496
0000-0003-3503-1694